Camber Pharma Launches Generic Jadenu®

Piscataway, NJ, August 31, 2021–Camber Pharmaceuticals is pleased to announce the addition of Deferasirox Tablets to their current portfolio.
A copay coupon is available with Camber’s Deferasirox Tablets. With some insurance plans, patients could have little-to-no copayment for this prescription.*
Deferasirox Tablets are used to treat iron overload caused by blood transfusions in adults and children at least 2 years old. Deferasirox Tablets are also used to treat chronic iron overload syndrome caused by a genetic blood disorder in adults and children who are at least 10 years old.
Deferasirox Tablets from Camber are available in 90, 180, and 360 mg strengths. All strengths are available in 30 count bottles.
Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
*Additional information about the copay coupon can be found on Camber’s Website.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection